KIMBERLY SCOTT: Open Payments
NPI 1104822295 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 39 payments from 6 companies in 2025. Trend: 2023 $452 · 2024 $439 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $256 |
| GlaxoSmithKline, LLC. | 12 | $247 |
| Optinose US, Inc. | 12 | $219 |
| GENZYME CORPORATION | 3 | $104 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Paratek Pharmaceuticals, Inc. | 1 | $31 |
Products named: DUPIXENT, XHANCE, NUCALA, Rhapsido.
Industry payments across VA — which companies pay providers there.
